Premium
Successful treatment of refractory bronchioloalveolar carcinoma with S‐1 (oral fluoropyrimidine)
Author(s) -
KOBAYASHI Seiichi,
FUJINO Naoya,
SUZUKI Satoshi,
YANAI Masaru
Publication year - 2009
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2009.01546.x
Subject(s) - medicine , refractory (planetary science) , lung cancer , carcinoma , oncology , chemotherapy , lung , physics , astrobiology
Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non‐small cell lung cancer for which there is no optimal therapy for non‐resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S‐1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S‐1 is a novel option for the treatment of advanced BAC.